Rethinking the Treatment of Pathologic Scars

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 13, Issue 2

Abstract

Over 100 million people develop a pathologic scar every year worldwide [1] Attempts to treat scars in the United States alone account for almost $15 Billion of expenditures with a large percentage of patients left with scars so symptomatic and impactful on daily life that they continue to seek treatment [2]. The Scar Free Foundation’s 2015 mandate to deliver scar free healing within a generation is a testament to the magnitude of this problem. Traditional theories about the causes of pathologic scar include fibroblast overgrowth, collagen overproduction, dysfunctional local immune response, presence of poorly encapsulated loose particles, endocrine irregularities, over or underproduction of cytokine mediators and presence of unique inflammatory cells. Recent understanding of the pathophysiology of scar is that it results from failure to progress through the normal phases of healing, from the inflammatory phase to the proliferative phase to the remodeling phase. It remains unknown how the dominant cells of each phase “hand off” to the dominant cells of the next phase and allow the wound to progress without becoming locked into a pro-fibrotic state that cannot resolve itself. In clinical practice, patients arrive with scars of highly variable etiology, time course and symptomatology which makes it impossible to establish rigid research protocols. Current scar treatment protocols include steroid injections, silicone pressure therapy, immunosuppressive agent injections, cryotherapy, surgery, radiation and laser as well as other less common methods. Some non-surgical methods of treatment include compression garments, massage, pulsed light, steroids, exercise and fat injections. The decision of which therapy to apply against a given scar is often the result of the most senior authority’s informed opinion or rigid adherence to an established protocol which accepts variable outcomes. Internationally recognized experts agree that current therapies are “not enough” [3]. Many clinical studies can show improvement on a given scar scale, but there is a persistently low adoption rate of any given protocol into clinical practice. The design of randomized controlled trials to match and compare therapies has been complicated by the wide variation of causal factors, demographics and lapse in time since the original injury. The impact of this level of imprecision and complexity is frustrating to both patients and practitioners alike as they try to match the right scar with the right treatment to get consistent and effective results. What works in one patient scenario may not work in the next. As a result, there exists a bewildering array of research-based and direct-to-consumer products available for use in the management of both pathologic and non-pathologic scars. This level of variation and complexity needs a more accurate and precise underlying organizational approach to unify research efforts and guide treatment choices. We see a need to develop a method of matching treatment to the specific scar of a specific patient at a specific time point in the scar’s maturation course.

Authors and Affiliations

Rahman Barry, Peter Ray, Hadiyah-Nicole Green

Keywords

Related Articles

Impact of Aquatic Salinity on Mangrove Seedlings: A Case Study on Heritiera fomes (Common Name: Sundari)

Heritiera fomes (commonly known as Sundari in India) is gradually getting extinct from high saline pockets of lower Gangetic plain. Hydroponically grown seedlings of the species were analyzed for Chl a, Chl b, total chlo...

Assessing Health Impact of Air Pollution in Macedonian Cities

Background: In regard the broad range of adverse health outcomes related to exposure to particulate air pollution, there are only few epidemiological data to be found for the countries of the former Yugoslav republics. P...

Biostatistical Analysis on Medicinal Plant Toxicity

Introduction/Aim: The incidences of medicinal plant toxicity in the society are becoming serious in the society. There is the need for scientist to determine the toxicity profile of most is therefore very important. Term...

Assessment of Dentists’ Knowledge Concerning the Management of Pregnant Women in the Dental Office

Introduction: Pregnancy is a physiological condition characterized by multiple changes in the entire woman’s body, including the oral cavity. Gingival hyperplasia, gingivitis, pyogenic granulomas and some salivary change...

Barriers of Discussion Concerning Sexual and Reproductive Health Issues Among Adolescents and Parents, Hawassa, SNNPR, Ethiopia

Background: Adolescence is a period of high developmental changes in physical, mental and social conditions. In this period the adolescent youth fails to control their emotions, listen to parents’ advice and begins to in...

Download PDF file
  • EP ID EP585842
  • DOI 10.26717/BJSTR.2019.13.002362
  • Views 145
  • Downloads 0

How To Cite

Rahman Barry, Peter Ray, Hadiyah-Nicole Green (2019). Rethinking the Treatment of Pathologic Scars. Biomedical Journal of Scientific & Technical Research (BJSTR), 13(2), 9797-9798. https://europub.co.uk/articles/-A-585842